RESEARCH from Neuroscience Research Australia (NeuRA) has reported promising results using intranasal insulin for patients with delirium, with benefits including reducing time spent in hospital.
Delirium - a sudden onset of confusion or drowsiness - affects more than 130,000 people each year in Australia, and up to 25% of hospitalised older people.
However, there are no proven pharmacological treatments.
The team evaluated the use of intranasal insulin as a treatment for delirium, reporting it resulted in a faster recovery, with patients being discharged five days earlier than those who received the placebo - "a very significant finding".
Researchers are calling for larger studies.
Read the paper HERE.
The above article was sent to subscribers in Pharmacy Daily's issue from 16 Oct 25
To see the full newsletter, see the embedded issue below or CLICK HERE to download Pharmacy Daily from 16 Oct 25
